167 related articles for article (PubMed ID: 27821080)
1. A prominent role of Hepatitis D Virus in liver cancers documented in Central Africa.
Amougou MA; Noah DN; Moundipa PF; Pineau P; Njouom R
BMC Infect Dis; 2016 Nov; 16(1):647. PubMed ID: 27821080
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis D virus infection, cirrhosis and hepatocellular carcinoma in The Gambia.
Mahale P; Aka P; Chen X; Pfeiffer RM; Liu P; Groover S; Mendy M; Njie R; Goedert JJ; Kirk GD; Glenn JS; O'Brien TR
J Viral Hepat; 2019 Jun; 26(6):738-749. PubMed ID: 30661282
[TBL] [Abstract][Full Text] [Related]
3. Incidence of hepatocellular carcinoma among older Americans attributable to hepatitis C and hepatitis B: 2001 through 2013.
Shiels MS; Engels EA; Yanik EL; McGlynn KA; Pfeiffer RM; O'Brien TR
Cancer; 2019 Aug; 125(15):2621-2630. PubMed ID: 30980394
[TBL] [Abstract][Full Text] [Related]
4. World-wide relative contribution of hepatitis B and C viruses in hepatocellular carcinoma.
de Martel C; Maucort-Boulch D; Plummer M; Franceschi S
Hepatology; 2015 Oct; 62(4):1190-200. PubMed ID: 26146815
[TBL] [Abstract][Full Text] [Related]
5. Birth order and risk of hepatocellular carcinoma in chronic carriers of hepatitis B virus: a case-control study in The Gambia.
Shimakawa Y; Lemoine M; Bottomley C; Njai HF; Ndow G; Jatta A; Tamba S; Bojang L; Taal M; Nyan O; D'Alessandro U; Njie R; Thursz M; Hall AJ
Liver Int; 2015 Oct; 35(10):2318-26. PubMed ID: 25728498
[TBL] [Abstract][Full Text] [Related]
6. Fraction and incidence of liver cancer attributable to hepatitis B and C viruses worldwide.
Maucort-Boulch D; de Martel C; Franceschi S; Plummer M
Int J Cancer; 2018 Jun; 142(12):2471-2477. PubMed ID: 29388206
[TBL] [Abstract][Full Text] [Related]
7. Multiple pregnancies, hepatitis C, and risk for hepatocellular carcinoma in Egyptian women.
Amr S; Iarocci EA; Nasr GR; Saleh D; Blancato J; Shetty K; Loffredo CA
BMC Cancer; 2014 Nov; 14():893. PubMed ID: 25432765
[TBL] [Abstract][Full Text] [Related]
8. Body mass index is associated with age-at-onset of HCV-infected hepatocellular carcinoma patients.
Akiyama T; Mizuta T; Kawazoe S; Eguchi Y; Kawaguchi Y; Takahashi H; Ozaki I; Fujimoto K
World J Gastroenterol; 2011 Feb; 17(7):914-21. PubMed ID: 21412500
[TBL] [Abstract][Full Text] [Related]
9. Immunological pathways in viral hepatitis-induced hepato-cellular carcinoma.
Xu L; Xu Y; Zhang F; Xu P; Wang L
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2024 Jan; 53(1):64-72. PubMed ID: 38426692
[TBL] [Abstract][Full Text] [Related]
10. Viral hepatitis: past and future of HBV and HDV.
Thomas E; Yoneda M; Schiff ER
Cold Spring Harb Perspect Med; 2015 Feb; 5(2):a021345. PubMed ID: 25646383
[TBL] [Abstract][Full Text] [Related]
11. International trends in hepatocellular carcinoma incidence, 1978-2012.
Petrick JL; Florio AA; Znaor A; Ruggieri D; Laversanne M; Alvarez CS; Ferlay J; Valery PC; Bray F; McGlynn KA
Int J Cancer; 2020 Jul; 147(2):317-330. PubMed ID: 31597196
[TBL] [Abstract][Full Text] [Related]
12. Epidemiology, Genotype Distribution, Prognosis, Control, and Management of Viral Hepatitis B, C, D, and Hepatocellular Carcinoma in Mongolia.
Baatarkhuu O; Gerelchimeg T; Munkh-Orshikh D; Batsukh B; Sarangua G; Amarsanaa J
Euroasian J Hepatogastroenterol; 2018; 8(1):57-62. PubMed ID: 29963464
[TBL] [Abstract][Full Text] [Related]
13. HBV induced HCC: major risk factors from genetic to molecular level.
Ayub A; Ashfaq UA; Haque A
Biomed Res Int; 2013; 2013():810461. PubMed ID: 23991421
[TBL] [Abstract][Full Text] [Related]
14. Hepatocellular carcinoma in Native South Asian Pakistani population; trends, clinico-pathological characteristics & differences in viral marker negative & viral-hepatocellular carcinoma.
Butt AS; Hamid S; Wadalawala AA; Ghufran M; Javed AA; Farooq O; Ahmed B; Ul Haq T; Jafri W
BMC Res Notes; 2013 Apr; 6():137. PubMed ID: 23566475
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis B virus infection and risk of colorectal cancer: a large, population-based cohort study from Israel.
Abu Baker F; Kopelman Y; Taher R; Abu Much S; Green I; Mari A; Davidov Y; Ben-Ari Z; Israel A
Minerva Med; 2024 Apr; 115(2):185-190. PubMed ID: 38197570
[TBL] [Abstract][Full Text] [Related]
16. Hepatocellular carcinoma: A global view.
Yang JD; Roberts LR
Nat Rev Gastroenterol Hepatol; 2010 Aug; 7(8):448-58. PubMed ID: 20628345
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathological criteria for multicentricity of hepatocellular carcinoma and risk factors for such carcinogenesis.
Kubo S; Nishiguchi S; Hirohashi K; Shuto T; Kuroki T; Minamitani S; Ikebe T; Yamamoto T; Wakasa K; Kinoshita H
Jpn J Cancer Res; 1998 Apr; 89(4):419-26. PubMed ID: 9617348
[TBL] [Abstract][Full Text] [Related]
18. A Longitudinal Analysis of Mortality Related to Chronic Viral Hepatitis and Hepatocellular Carcinoma in the United States.
Ozturk NB; Pham HN; Mouhaffel R; Ibrahim R; Alsaqa M; Gurakar A; Saberi B
Viruses; 2024 Apr; 16(5):. PubMed ID: 38793576
[TBL] [Abstract][Full Text] [Related]
19. Aflatoxin contamination in food and body fluids in relation to malnutrition and cancer status in Cameroon.
Tchana AN; Moundipa PF; Tchouanguep FM
Int J Environ Res Public Health; 2010 Jan; 7(1):178-88. PubMed ID: 20195440
[TBL] [Abstract][Full Text] [Related]
20. Molecular Analysis of HBV in Histologically Confirmed Hepatocellular Carcinoma in a Tertiary Hospital in Ghana.
Duduyemi BM; Asante DB; Titiloye NA; Ohene-Nketia B; Sa A
Niger Med J; 2022; 63(2):147-154. PubMed ID: 38803700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]